IDrugs | Most viewed articles in past year

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries jobs about my BioMed Central home journals A-Z subject areas advanced search authors reviewers libraries jobs about my BioMed Central

Quick Search

	IDrugs
	BioMed Central
	PubMed Central
	PubMed

Jump to article


vol.	page no.

IDrugs

Most viewed

IDrugs: Most viewed articles in past year

[more info]

Figures given indicate the abstract, full text and PDF accesses on BioMed Central for each article, over the last year. All research articles are also available via the PubMed Central archive, so the total number of accesses to each article is significantly higher. Lists of most-viewed articles over the last 30 days and of all time most-viewed articles are also available

most viewed articles over the last year from all BioMed Central Journals

1. Accesses 557	Erratum Erratum - Drug evaluation: Deferitrin (GT-56-252; NaHBED) for iron overload disorders JC Barton IDrugs 2007, 10:480-490 (6July2007) [PDF] [PubMed] [Related articles]
2. Accesses 154	Feature review Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: Challenges and feasibility FK Knop, JJ Holst, T Vilsbll IDrugs 2008, 11:497-501 (2July2008) [PDF] [PubMed] [Related articles]
3. Accesses 119	Feature review Advances in the development of siRNA-based therapeutics for cancer Y Shen IDrugs 2008, 11:572-578 (31July2008) [PDF] [PubMed] [Related articles]
4. Accesses 118	Feature review RNAi-based drug discovery and its application to therapeutics N Hokaiwado, F Takeshita, A Banas, T Ochiya IDrugs 2008, 11:274-278 (27March2008) [PDF] [PubMed] [Related articles]
5. Accesses 97	Meeting report American Society of Clinical Oncology - 44th Annual Meeting. Reports of clinical trial results Part 2 E Ogbighele IDrugs 2008, 11:547-549 (31July2008) [PDF] [PubMed] [Related articles]
6. Accesses 92	Review Drug evaluation: PTC-124 - a potential treatment of cystic fibrosis and Duchenne muscular dystrophy SA Hamed IDrugs 2006, 9:783-789 (27October2006) [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
7. Accesses 92	Feature review Designing new treatments for depression and anxiety Z Chen, J Yang, A Tobak IDrugs 2008, 11:189-197 (28February2008) [PDF] [PubMed] [Related articles]
8. Accesses 84	Review Nilotinib a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of chronic myelocytic leukemia and beyond E Jabbour, J Cortes, F Giles, S O'Brien, H Kantarijan IDrugs 2007, 10:468-479 (6July2007) [PDF] [PubMed] [Related articles]
9. Accesses 83	Review Hepatocellular carcinoma (HCC): Current and evolving therapies RG Gish, A Baron IDrugs 2008, 11:198-203 (28February2008) [PDF] [PubMed] [Related articles]
10. Accesses 80	Feature review High-content assays in oncology drug discovery: Opportunities and challenges Eh Mouchet, PB Simpson IDrugs 2008, 11:422-427 (28May2008) [PDF] [PubMed] [Related articles]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us